McAuley et al. of the Ohio State University College of Pharmacy evaluated the concerns of women with epilepsy about the use of antiepileptic drugs during pregnancy in a small-group symposium format and published the results in a recent issue of Epilepsy & Behavior. Twenty-one patients with epilepsy during pregnancy were included in the study, and 10 group symposia were organized. The analysis showed that 12 women changed their medication regimen during pregnancy, six of them at the request of the prescribing physician and the remaining six at their own decision to reduce or stop their medication (29% of those who changed their medication regimen). Patients’ concerns about medication use included: 1. the safety of medication use during pregnancy. 2. potential neonatal complications. 3. impact on delivery. 4. the impact on neonatal and maternal care. The study also had an unintended benefit: the group sessions had a reassuring effect on patients and increased patient cooperation. The study suggests that by identifying patients’ medication concerns, more effective patient education can be provided, which may improve prognosis.